|
|||||
|
|
Cardiovascular safety of degarelix: results from a 12-month, comparative, randomized, open label, parallel group phase III trial in patients with prostate cancer |
|
| Authors: | Smith Matthew R Klotz Laurence Persson Bo-Eric Olesen Tine Kold Wilde Arthur A M |
| Affiliation: | aMassachusetts General Hospital Cancer Center, Boston, Massachusetts;bDivision of Urology, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada;cFerring Pharmaceuticals, Saint-Prex, Switzerland;dClinical Research & Development Urology, Ferring Pharmaceuticals A/S, Copenhagen, Denmark;eDepartment of Cardiology, Heart Failure Research Centre, The Academic Medical Center, Amsterdam, The Netherlands |
| Abstract: | |
| Keywords: | adenocarcinoma gonadotropin-releasing hormone drug monitoring |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |